Adamu Abdu A, Jalo Rabiu I, Ndwandwe Duduzile, Wiysonge Charles S
Cochrane South Africa, South African Medical Research Council, Francie van Zijl Drive, Parrow Valley, Cape Town 7500, South Africa.
Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Francie van Zijl Drive, Tygerberg, Cape Town 7505, South Africa.
Vaccines (Basel). 2024 Jan 23;12(2):111. doi: 10.3390/vaccines12020111.
In 2019, national immunization programs in Ghana, Kenya, and Malawi commenced the implementation of RTS,S/AS01 vaccination in large-scale pilot schemes. Understanding the implementation context of this malaria vaccination in the pilot countries can provide useful insights for enhancing implementation outcomes in new countries. There has not yet been a proper synthesis of the implementation determinants of malaria vaccination programs. A rapid review was conducted to identify the implementation determinants of the pilot malaria vaccination programs in Ghana, Kenya, and Malawi, and describe the mechanism by which these determinants interact with each other. A literature search was conducted in November 2023 in PubMed and Google Scholar to identify those studies that described the factors affecting malaria vaccine implementation in Ghana, Kenya, and Malawi. Thirteen studies conducted between 2021 and 2023 were included. A total of 62 implementation determinants of malaria vaccination across all five domains of the consolidated framework for implementation research (CFIR) were identified. A causal loop diagram showed that these factors are interconnected and interrelated, identifying nine reinforcing loops and two balancing loops. As additional countries in Africa prepare for a malaria vaccine roll-out, it is pertinent to ensure that they have access to adequate information about the implementation context of countries that are already implementing malaria vaccination programs so that they understand the potential barriers and facilitators. This information can be used to inform context-specific systems enhancement to maximize implementation success. Going forward, primary implementation studies that incorporate the causal loop diagram should be integrated into the malaria vaccine implementation program to enable immunization program managers and other key stakeholders to identify and respond to emerging implementation barriers in a timely and systematic manner, to improve overall implementation performance.
2019年,加纳、肯尼亚和马拉维的国家免疫规划在大规模试点项目中开始实施RTS,S/AS01疫苗接种。了解试点国家中这种疟疾疫苗接种的实施情况,可为提高其他新国家的实施效果提供有益见解。目前尚未对疟疾疫苗接种项目的实施决定因素进行恰当的综合分析。为此进行了一项快速综述,以确定加纳、肯尼亚和马拉维试点疟疾疫苗接种项目的实施决定因素,并描述这些决定因素相互作用的机制。2023年11月在PubMed和谷歌学术上进行了文献检索,以找出那些描述影响加纳、肯尼亚和马拉维疟疾疫苗实施因素的研究。纳入了2021年至2023年期间开展的13项研究。在实施研究综合框架(CFIR)的所有五个领域中,共确定了62个疟疾疫苗接种的实施决定因素。因果循环图显示,这些因素相互关联,识别出九个增强回路和两个平衡回路。随着非洲其他国家准备推出疟疾疫苗,确保它们能够获得有关已实施疟疾疫苗接种项目国家实施情况的充分信息非常重要,这样它们就能了解潜在的障碍和促进因素。这些信息可用于为因地制宜的系统强化提供参考,以最大限度地提高实施成功率。展望未来,应将纳入因果循环图的主要实施研究纳入疟疾疫苗实施项目,使免疫规划管理人员和其他关键利益相关者能够及时、系统地识别并应对新出现的实施障碍,以提高整体实施绩效。